Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 53

Cited In for PubMed (Select 8497041)

1.

Evolution of oseltamivir resistance mutations in Influenza A(H1N1) and A(H3N2) viruses during selection in experimentally infected mice.

Pizzorno A, Abed Y, Plante PL, Carbonneau J, Baz M, Hamelin MÈ, Corbeil J, Boivin G.

Antimicrob Agents Chemother. 2014 Nov;58(11):6398-405. doi: 10.1128/AAC.02956-14. Epub 2014 Aug 11.

PMID:
25114143
2.

A novel I221L substitution in neuraminidase confers high-level resistance to oseltamivir in influenza B viruses.

Escuret V, Collins PJ, Casalegno JS, Vachieri SG, Cattle N, Ferraris O, Sabatier M, Frobert E, Caro V, Skehel JJ, Gamblin S, Valla F, Valette M, Ottmann M, McCauley JW, Daniels RS, Lina B.

J Infect Dis. 2014 Oct 15;210(8):1260-9. doi: 10.1093/infdis/jiu244. Epub 2014 May 3.

3.

Fitness costs for Influenza B viruses carrying neuraminidase inhibitor-resistant substitutions: underscoring the importance of E119A and H274Y.

Burnham AJ, Baranovich T, Marathe BM, Armstrong J, Webster RG, Govorkova EA.

Antimicrob Agents Chemother. 2014 May;58(5):2718-30. doi: 10.1128/AAC.02628-13. Epub 2014 Feb 24.

4.

A conformational restriction in the influenza A virus neuraminidase binding site by R152 results in a combinational effect of I222T and H274Y on oseltamivir resistance.

Huang L, Cao Y, Zhou J, Qin K, Zhu W, Zhu Y, Yang L, Wang D, Wei H, Shu Y.

Antimicrob Agents Chemother. 2014;58(3):1639-45. doi: 10.1128/AAC.01848-13. Epub 2013 Dec 23.

5.

Genetic characterization of seasonal influenza A (H3N2) viruses in Ontario during 2010-2011 influenza season: high prevalence of mutations at antigenic sites.

Eshaghi A, Duvvuri VR, Li A, Patel SN, Bastien N, Li Y, Low DE, Gubbay JB.

Influenza Other Respir Viruses. 2014 Mar;8(2):250-7. doi: 10.1111/irv.12219. Epub 2013 Dec 6.

6.

Emergence of an oseltamivir-resistant influenza A/H3N2 virus in an elderly patient receiving a suboptimal dose of antiviral prophylaxis.

Roussy JF, Abed Y, Bouhy X, Boivin G.

J Clin Microbiol. 2013 Dec;51(12):4234-6. doi: 10.1128/JCM.02659-13. Epub 2013 Oct 2.

7.

Neuraminidase inhibitors for influenza B virus infection: efficacy and resistance.

Burnham AJ, Baranovich T, Govorkova EA.

Antiviral Res. 2013 Nov;100(2):520-34. doi: 10.1016/j.antiviral.2013.08.023. Epub 2013 Sep 4. Review.

8.

Cross-reactive human B cell and T cell epitopes between influenza A and B viruses.

Terajima M, Babon JA, Co MD, Ennis FA.

Virol J. 2013 Jul 26;10:244. doi: 10.1186/1743-422X-10-244. Review.

9.

Genetic Analysis of Avian Influenza Viruses: Cocirculation of Avian Influenza Viruses with Allele A and B Nonstructural Gene in Northern Pintail (Anas acuta) Ducks Wintering in Japan.

Jahangir A, Ruenphet S, Sultana N, Shoham D, Takehara K.

Influenza Res Treat. 2012;2012:847505. doi: 10.1155/2012/847505. Epub 2012 Dec 25.

10.

Molecular mechanisms underlying oseltamivir resistance mediated by an I117V substitution in the neuraminidase of subtype H5N1 avian influenza A viruses.

Takano R, Kiso M, Igarashi M, Le QM, Sekijima M, Ito K, Takada A, Kawaoka Y.

J Infect Dis. 2013 Jan 1;207(1):89-97. doi: 10.1093/infdis/jis633. Epub 2012 Oct 10.

11.

Influenza virus neuraminidase: structure and function.

Shtyrya YA, Mochalova LV, Bovin NV.

Acta Naturae. 2009 Jul;1(2):26-32.

12.

Recovery of influenza B virus with the H273Y point mutation in the neuraminidase active site from a human patient.

Higgins RR, Beniprashad M, Chong-King E, Li Y, Bastien N, Low DE, Gubbay JB.

J Clin Microbiol. 2012 Jul;50(7):2500-2. doi: 10.1128/JCM.00682-12. Epub 2012 Apr 25.

13.

Contribution of antibody production against neuraminidase to the protection afforded by influenza vaccines.

Marcelin G, Sandbulte MR, Webby RJ.

Rev Med Virol. 2012 Jul;22(4):267-79. doi: 10.1002/rmv.1713. Epub 2012 Mar 22. Review.

14.

Impact of mutations at residue I223 of the neuraminidase protein on the resistance profile, replication level, and virulence of the 2009 pandemic influenza virus.

Pizzorno A, Abed Y, Bouhy X, Beaulieu E, Mallett C, Russell R, Boivin G.

Antimicrob Agents Chemother. 2012 Mar;56(3):1208-14. doi: 10.1128/AAC.05994-11. Epub 2011 Dec 27.

15.

Role of permissive neuraminidase mutations in influenza A/Brisbane/59/2007-like (H1N1) viruses.

Abed Y, Pizzorno A, Bouhy X, Boivin G.

PLoS Pathog. 2011 Dec;7(12):e1002431. doi: 10.1371/journal.ppat.1002431. Epub 2011 Dec 8.

16.

Amino acid changes in hemagglutinin contribute to the replication of oseltamivir-resistant H1N1 influenza viruses.

Ginting TE, Shinya K, Kyan Y, Makino A, Matsumoto N, Kaneda S, Kawaoka Y.

J Virol. 2012 Jan;86(1):121-7. doi: 10.1128/JVI.06085-11. Epub 2011 Oct 19.

17.

Neuraminidase inhibitor susceptibility testing in human influenza viruses: a laboratory surveillance perspective.

Okomo-Adhiambo M, Sleeman K, Ballenger K, Nguyen HT, Mishin VP, Sheu TG, Smagala J, Li Y, Klimov AI, Gubareva LV.

Viruses. 2010 Oct;2(10):2269-89. doi: 10.3390/v2102269. Epub 2010 Oct 13. Erratum in: Viruses. 2011 Aug;3(8):1415-6.

18.

Detection of an influenza B virus strain with reduced susceptibility to neuraminidase inhibitor drugs.

Bastien N, Gubbay JB, Richardson D, Sleeman K, Gubareva L, Li Y.

J Clin Microbiol. 2011 Nov;49(11):4020-1. doi: 10.1128/JCM.05069-11. Epub 2011 Sep 7. No abstract available.

19.

A molecular and antigenic survey of H5N1 highly pathogenic avian influenza virus isolates from smallholder duck farms in Central Java, Indonesia during 2007-2008.

Wibawa H, Henning J, Wong F, Selleck P, Junaidi A, Bingham J, Daniels P, Meers J.

Virol J. 2011 Sep 7;8:425. doi: 10.1186/1743-422X-8-425.

20.

Combinatorial effect of two framework mutations (E119V and I222L) in the neuraminidase active site of H3N2 influenza virus on resistance to oseltamivir.

Richard M, Ferraris O, Erny A, Barthélémy M, Traversier A, Sabatier M, Hay A, Lin YP, Russell RJ, Lina B.

Antimicrob Agents Chemother. 2011 Jun;55(6):2942-52. doi: 10.1128/AAC.01699-10. Epub 2011 Mar 21.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk